A systematic review of rapid drug susceptibility tests for multidrug-resistant tuberculosis using rifampin resistance as a surrogate

Bibliography

• World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO/HTM/TB/2008.393. Geneva, Switzerland: WHO, 2008
   Google Scholar
• World Health Organization. Treatment of tuberculosis: guidelines for national programmes. Third edition. WHO/CDS/TB/2003.313. Geneva, Switzerland: WHO, 2003
   Google Scholar
• World Health Organization. Anti-tuberculosis drug resistance in the world. Fourth global report. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance 2002-2007. WHO/HTM/TB/2008.394. Geneva, Switzerland: WHO, 2008
   Google Scholar
• Yew WW, Leung CC. Management of multidrug-resistant tuberculosis: Update 2007. Respirology 2008;13:21-46
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs–worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 2006;55:301-5
   PubMedGoogle Scholar
• Espinal MA, Laserson K, Camacho M, et al. Determinants of drug-resistant tuberculosis: analysis of 11 countries. Int J Tuberc Lung Dis 2001;5:887-93
   PubMed Web of Science ®Google Scholar
• Zhang Y. Persistent and dormant tubercle bacilli and latent tuberculosis. Front Biosci 2004;9:1136-56
   PubMed Web of Science ®Google Scholar
• Zhang Y. The magic bullets and tuberculosis drug targets. Annu Rev Pharmacol Toxicol 2005;45:529-64
   PubMed Web of Science ®Google Scholar
• Canetti G, Fox W, Khomenko A, et al. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 1969;41:21-43
   PubMed Web of Science ®Google Scholar
• Park MM, Davis AL, Schluger NW, et al. Outcome of MDR-TB patients, 1983-1993. Prolonged survival with appropriate therapy. Am J Respir Crit Care Med 1996;153:317-24
   PubMed Web of Science ®Google Scholar
• Caminero JA. World Health Organization, American Thoracic Society, British Thoracic Society. Treatment of multidrug-resistant tuberculosis: evidence and controversies. Int J Tuberc Lung Dis 2006;10:829-37
   PubMed Web of Science ®Google Scholar
• Hong Kong Chest Service/British Medical Research Council. Five-year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis. Am Rev Respir Dis 1987;136:1339-42
   PubMed Web of Science ®Google Scholar
• Mphahlele M, Syre H, Valvatne H, et al. Pyrazinamide resistance among South African multidrug-resistant Mycobacterium tuberculosis isolates. J Clin Microbiol 2008;46:3459-64
   PubMed Web of Science ®Google Scholar
• Mitchison DA, Nunn AJ. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. Am Rev Respir Dis 1986;133:423-30
   PubMed Web of Science ®Google Scholar
• Watterson SA, Wilson SM, Yates MD, Drobniewski FA. Comparison of three molecular assays for rapid detection of rifampin resistance in Mycobacterium tuberculosis. J Clin Microbiol 1998;36:1969-73
   PubMed Web of Science ®Google Scholar
• Telenti A, Imboden P, Marchesi F, et al. Direct, automated detection of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysis. Antimicrob Agents Chemother 1993;37:2054-8
   PubMed Web of Science ®Google Scholar
• Telenti A, Imboden P, Marchesi F, et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 1993;341:647-50
   PubMed Web of Science ®Google Scholar
• Telenti A, Honore N, Bernasconi C, et al. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol 1997;35:719-23
   PubMed Web of Science ®Google Scholar
• Kapur V, Li LL, Iordanescu S, et al. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J Clin Microbiol 1994;32:1095-8
   PubMed Web of Science ®Google Scholar
• Williams DL, Waguespack C, Eisenach K, et al. Characterization of rifampin-resistance in pathogenic mycobacteria. Antimicrob Agents Chemother 1994;38:2380-6
   PubMed Web of Science ®Google Scholar
• Musser JM. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev 1995;8:496-514
   PubMed Web of Science ®Google Scholar
• Traore H, Fissette K, Bastian I, et al. Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance. Int J Tuberc Lung Dis 2000;4:481-4
   PubMed Web of Science ®Google Scholar
• Zhang Y, Heym B, Allen B, et al. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 1992;358:591-3
   PubMed Web of Science ®Google Scholar
• Banerjee A, Dubnau E, Quemard A, et al. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 1994;263:227-30
   PubMed Web of Science ®Google Scholar
• Scorpio A, Zhang Y. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat Med 1996;2:662-7
   PubMed Web of Science ®Google Scholar
• Telenti A, Philipp WJ, Sreevatsan S, et al. The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat Med 1997;3:567-70
   PubMed Web of Science ®Google Scholar
• Finken M, Kirschner P, Meier A, et al. Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot. Mol Microbiol 1993;9:1239-46
   PubMed Web of Science ®Google Scholar
• Okamoto S, Tamaru A, Nakajima C, et al. Loss of a conserved 7-methylguanosine modification in 16S rRNA confers low-level streptomycin resistance in bacteria. Mol Microbiol 2007;63:1096-106
   PubMed Web of Science ®Google Scholar
• Wade MM, Zhang Y. Mechanisms of drug resistance in Mycobacterium tuberculosis. Front Biosci 2004;9:975-94
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jacobs WR Jr. Mechanisms of drug action, drug resistance and drug tolerance in Mycobacterium tuberculosis: expected phenotypes from evolutionary pressures from a highly successful pathogen. In: Kaufmann SHE, Rubin E, editors. Handbook of tuberculosis. KGaA, Weinheim, Germany: Wiley-VCH Verlag GmbH & Co; 2008. vol 1 p. 323-78
   Google Scholar
• Heym B, Honore N, Truffot-Pernot C, et al. Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study. Lancet 1994;344:293-8
   PubMed Web of Science ®Google Scholar
• Sekiguchi J, Nakamura T, Miyoshi-Akiyama T, et al. Development and evaluation of a line probe assay for rapid identification of pncA mutations in pyrazinamide-resistant mycobacterium tuberculosis strains. J Clin Microbiol 2007;45:2802-7
   PubMed Web of Science ®Google Scholar
• Zhang Y, Mitchison D. The curious characteristics of pyrazinamide: a review. Int J Tuberc Lung Dis 2003;7:6-21
   PubMed Web of Science ®Google Scholar
• Troesch A, Nguyen H, Miyada CG, et al. Mycobacterium species identification and rifampin resistance testing with high-density DNA probe arrays. J Clin Microbiol 1999;37:49-55
   PubMed Web of Science ®Google Scholar
• Wade MM, Volokhov D, Peredelchuk M, et al. Accurate mapping of mutations of pyrazinamide-resistant Mycobacterium tuberculosis strains with a scanning-frame oligonucleotide microarray. Diagn Microbiol Infect Dis 2004;49:89-97
   PubMed Web of Science ®Google Scholar
• Brown TJ, Herrera-Leon L, Anthony RM, Drobniewski FA. The use of macroarrays for the identification of MDR Mycobacterium tuberculosis. J Microbiol Methods 2006;65:294-300
   PubMed Web of Science ®Google Scholar
• Shamputa IC, Rigouts And L, Portaels F. Molecular genetic methods for diagnosis and antibiotic resistance detection of mycobacteria from clinical specimens. APMIS 2004;112:728-52
   PubMed Web of Science ®Google Scholar
• Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance. Expert Rev Mol Diagn 2006;6:423-32
   PubMed Web of Science ®Google Scholar
• Lin SG, Probert W, Lo M, Desmond E. Rapid detection of isoniazid and rifampin resistance mutations in Mycobacterium tuberculosis complex from cultures or smear-positive sputa by use of molecular beacons. J Clin Microbiol 2004;42:4204-8
   PubMed Web of Science ®Google Scholar
• Raut U, Narang P, Mendiratta DK, et al. Evaluation of rapid MTT tube method for detection of drug susceptibility of Mycobacterium tuberculosis to rifampicin and isoniazid. Indian J Med Microbiol 2008;26:222-7
   PubMed Web of Science ®Google Scholar
• Coban AY, Cekic Cihan C, Bilgin K, et al. Rapid susceptibility test for Mycobacterium tuberculosis to isoniazid and rifampin with resazurin method in screw-cap tubes. J Chemother 2006;18:140-3
   PubMed Web of Science ®Google Scholar
• Kahn A, Groswasser J, Rebuffat E, et al. Sleep and cardiorespiratory characteristics of infant victims of sudden death: a prospective case-control study. Sleep 1992;15:287-92
   PubMed Web of Science ®Google Scholar
• Yajko DM, Madej JJ, Lancaster MV, et al. Colorimetric method for determining MICs of antimicrobial agents for Mycobacterium tuberculosis. J Clin Microbiol 1995;33:2324-7
   PubMed Web of Science ®Google Scholar
• Golyshevskaia VI, Korneev AA, Chernousova LN, et al. New microbiological Techniques in diagnosis of tuberculosis. Probl Tuberk 1996;6:22-5
   PubMedGoogle Scholar
• Griess JP. Bemerkungen zu der Abhandlung der. HH: Wesely und Benedikt. Uber einige Azoverbindungen. Ber Deutsch Chem Ges 1879;12:426-8
   Google Scholar
• Montoro E, Lemus D, Echemendia M, et al. Comparative evaluation of the nitrate reduction assay, the MTT test, and the resazurin microtitre assay for drug susceptibility testing of clinical isolates of Mycobacterium tuberculosis. J Antimicrob Chemother 2005;55:500-5
   PubMed Web of Science ®Google Scholar
• Poojary A, Nataraj G, Kanade S, et al. Rapid antibiotic susceptibility testing of Mycobacterium tuberculosis: its utility in resource poor settings. Indian J Med Microbiol 2006;24:268-72
   PubMedGoogle Scholar
• Affolabi D, Odoun M, Sanoussi N, et al. Rapid and Inexpensive Detection of Multidrug Resistant Tuberculosis with the Nitrate Reductase Assay using Liquid Medium and Applied directly to Sputum Samples. J Clin Microbiol 2008;46:3243-5
   PubMed Web of Science ®Google Scholar
• Caviedes L, Lee TS, Gilman RH, et al. Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru. J Clin Microbiol 2000;38:1203-8
   PubMed Web of Science ®Google Scholar
• Moore DAJ, Evans CAW, Gilman RH, et al. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 2006;355:1539-50
   PubMed Web of Science ®Google Scholar
• Morgan M, Kalantri S, Flores L, Pai M. A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. BMC Infect Dis 2005;5:62
   PubMed Web of Science ®Google Scholar
• Ling DI, Zwerling AA, Pai M. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur Respir J 2008. Published online 9 Jul 2008, doi:10.1183/09031936.00061808
   Google Scholar
• Martin A, Portaels F, Palomino JC. Colorimetric redox-indicator methods for the rapid detection of multidrug resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother 2007;59:175-83
   PubMed Web of Science ®Google Scholar
• Martin A, Panaiotov S, Portaels F, et al. The nitrate reductase assay for the rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother 2008;62:56-64
   PubMed Web of Science ®Google Scholar
• Pai M, Kalantri S, Pascopella L, et al. Bacteriophage-based assays for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a meta-analysis. J Infect 2005;51:175-87
   PubMed Web of Science ®Google Scholar
• Agresti A. Analysis of ordinal categorical data. New York: John Wileys & Sons; 1984
   Google Scholar
• Deeks JJ. Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ 2001;323:157-62
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60
   PubMed Web of Science ®Google Scholar
• Miotto P, Piana F, Cirillo DM, Migliori GB. Genotype MTBDRplus: a further step toward rapid identification of drug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2008;46:393-4
   PubMed Web of Science ®Google Scholar
• Barnard M, Albert H, Coetzee G, et al. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med 2008;177:787-92
   PubMed Web of Science ®Google Scholar
• Ruiz M, Torres MJ, Llanos AC, et al. Direct detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis in auramine-rhodamine-positive sputum specimens by real-time PCR. J Clin Microbiol 2004;42:1585-9
   PubMed Web of Science ®Google Scholar
• Albert H, Trollip AP, Seaman T, et al. Evaluation of a rapid screening test for rifampicin resistance in re-treatment tuberculosis patients in the Eastern Cape. S Afr Med J 2007;97:858-63
   PubMed Web of Science ®Google Scholar
• Albert H, Trollip A, Seaman T, Mole RJ. Simple, phage-based (FASTPplaque) technology to determine rifampicin resistance of Mycobacterium tuberculosis directly from sputum. Int J Tuberc Lung Dis 2004;8:1114-9
   PubMed Web of Science ®Google Scholar
• Farnia P, Masjedi MR, Mohammadi F, et al. Colorimetric detection of multidrug-resistant or extensively drug-resistant tuberculosis by use of malachite green indicator dye. J Clin Microbiol 2008;46:796-9
   PubMed Web of Science ®Google Scholar
• Kim BJ, Lee KH, Park BN, et al. Detection of rifampin-resistant Mycobacterium tuberculosis in sputa by nested PCR-linked single-strand conformation polymorphism and DNA sequencing. J Clin Microbiol 2001;39:2610-7
   PubMed Web of Science ®Google Scholar
• Abate G, Aseffa A, Selassie A, et al. Direct colorimetric assay for rapid detection of rifampin-resistant Mycobacterium tuberculosis. J Clin Microbiol 2004;42:871-3
   PubMed Web of Science ®Google Scholar
• Scarpellini P, Braglia S, Carrera P, et al. Detection of rifampin resistance in Mycobacterium tuberculosis by double gradient-denaturing gradient gel electrophoresis. Antimicrob Agents Chemother 1999;43:2550-4
   PubMed Web of Science ®Google Scholar
• Affolabi D, Odoun M, Martin A, et al. Evaluation of direct detection of Mycobacterium tuberculosis rifampin resistance by a nitrate reductase assay applied to sputum samples in Cotonou, Benin. J Clin Microbiol 2007;45:2123-5
   PubMed Web of Science ®Google Scholar
• Solis LA, Shin SS, Han LL, et al. Validation of a rapid method for detection of M. tuberculosis resistance to isoniazid and rifampin in Lima, Peru. Int J Tuberc Lung Dis 2005;9:760-4
   PubMed Web of Science ®Google Scholar
• Musa HR, Ambroggi M, Souto A, Angeby KAK. Drug susceptibility testing of Mycobacterium tuberculosis by a nitrate reductase assay applied directly on microscopy-positive sputum samples. J Clin Microbiol 2005;43:3159-61
   PubMed Web of Science ®Google Scholar
• De Beenhouwer H, Lhiang Z, Jannes G, et al. Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. Tuber Lung Dis 1995;76:425-30
   PubMedGoogle Scholar
• Johansen IS, Lundgren B, Sosnovskaja A, Thomsen VO. Direct detection of multidrug-resistant Mycobacterium tuberculosis in clinical specimens in low- and high-incidence countries by line probe assay. J Clin Microbiol 2003;41:4454-6
   PubMed Web of Science ®Google Scholar
• Viveiros M, Leandro C, Rodrigues L, et al. Direct application of the INNO-LiPA Rif.TB line-probe assay for rapid identification of Mycobacterium tuberculosis complex strains and detection of rifampin resistance in 360 smear-positive respiratory specimens from an area of high incidence of multidrug-resistant tuberculosis. J Clin Microbiol 2005;43:4880-4
   PubMed Web of Science ®Google Scholar
• Hillemann D, Rusch-Gerdes S, Richter E. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol 2007;45:2635-40
   PubMed Web of Science ®Google Scholar
• Somoskovi A, Dormandy J, Mitsani D, et al. Use of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin. J Clin Microbiol 2006;44:4459-63
   PubMed Web of Science ®Google Scholar
• Hillemann D, Rusch-Gerdes S, Richter E. Application of the Genotype MTBDR assay directly on sputum specimens. Int J Tuberc Lung Dis 2006;10:1057-9
   PubMed Web of Science ®Google Scholar
• Bang D, Bengard Andersen A, Thomsen VO. Rapid genotypic detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis directly in clinical specimens. J Clin Microbiol 2006;44:2605-8
   PubMed Web of Science ®Google Scholar
• Albert H, Heydenrych A, Brookes R, et al. Performance of a rapid phage-based test, FASTPlaqueTB, to diagnose pulmonary tuberculosis from sputum specimens in South Africa. Int J Tuberc Lung Dis 2002;6:529-37
   PubMed Web of Science ®Google Scholar
• Muzaffar R, Batool S, Aziz F, et al. Evaluation of the FASTPlaqueTB assay for direct detection of Mycobacterium tuberculosis in sputum specimens. Int J Tuberc Lung Dis 2002;6:635-40
   PubMed Web of Science ®Google Scholar
• Mole R, Trollip A, Abrahams C, et al. Improved contamination control for a rapid phage-based rifampicin resistance test for Mycobacterium tuberculosis. J Med Microbiol 2007;56:1334-9
   PubMed Web of Science ®Google Scholar
• World Health Organization. Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB): policy statement. Geneva, Switzerland: WHO, 2008
   Google Scholar
• Grandjean L, Moore DAJ. Tuberculosis in the developing world: recent advances in diagnosis with special consideration of extensively drug-resistant tuberculosis. Curr Opin Infect Dis 2008;21:454-61
   PubMed Web of Science ®Google Scholar
• Acuna-Villaorduna C, Vassall A, Henostroza G, et al. Cost-effectiveness analysis of introduction of rapid, alternative methods to identify multidrug-resistant tuberculosis in middle-income countries. Clin Infect Dis 2008;47:487-95
   PubMed Web of Science ®Google Scholar
• Cavusoglu C, Hilmioglu S, Guneri S, Bilgic A. Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay. J Clin Microbiol 2002;40:4435-8
   PubMed Web of Science ®Google Scholar
• Chan RCY, Hui M, Chan EWC, et al. Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong. J Antimicrob Chemother 2007;59:866-73
   PubMed Web of Science ®Google Scholar
• World Health Organization. Anti-tuberculosis drug resistance in the world. Report No. 3. The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance. WHO/HTM/TB/2004.343. Geneva, Switzerland: WHO, 2004
   Google Scholar
• Migliori GB, Besozzi G, Girardi E, et al. Clinical and operational value of the extensively drug-resistant tuberculosis definition. Eur Respir J 2007;30:623-6
   PubMed Web of Science ®Google Scholar
• Giannoni F, Iona E, Sementilli F, et al. Evaluation of a new line probe assay for rapid identification of gyrA mutations in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2005;49:2928-33
   PubMed Web of Science ®Google Scholar
• Cheng AFB, Yew WW, Chan EWC, et al. Multiplex PCR amplimer conformation analysis for rapid detection of gyrA mutations in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates. Antimicrob Agents Chemother 2004;48:596-601
   PubMed Web of Science ®Google Scholar
• Yew WW, Chan E, Chan CY, Cheng AF. Genotypic and phenotypic resistance of Mycobacterium tuberculosis to rifamycins and fluoroquinolones. Int J Tuberc Lung Dis 2002;6:936-7
   PubMed Web of Science ®Google Scholar
• Siddiqi N, Shamim M, Hussain S, et al. Molecular characterization of multidrug-resistant isolates of Mycobacterium tuberculosis from patients in North India. Antimicrob Agents Chemother 2002;46:443-50
   PubMed Web of Science ®Google Scholar
• Huang T, Kunin CM, Shin-Jung LEE, et al. Trends in fluoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwanese medical centre: 1995-2003. J Antimicrob Chemother 2005;56:1058-62
   PubMed Web of Science ®Google Scholar
• Lee ASG, Tang LLH, Lim IHK, Wong SY. Characterization of pyrazinamide and ofloxacin resistance among drug resistant Mycobacterium tuberculosis isolates from Singapore. Int J Infect Dis 2002;6:48-51
   PubMedGoogle Scholar
• Zhao JR, Bai YJ, Zhang QH, et al. Pyrosequencing-based approach for rapid detection of rifampin-resistant Mycobacterium tuberculosis. Diagn Microbiol Infect Dis 2005;51:135-7
   PubMed Web of Science ®Google Scholar
• Zhao J, Bai Y, Wang Y, et al. Development of a pyrosequencing approach for rapid screening of rifampin, isoniazid and ethambutol-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2005;9:328-32
   PubMed Web of Science ®Google Scholar
• Marttila H, Makinen J, Marjamaki M, Soini H. Prospective evaluation of pyrosequencing for the rapid detection of isoniazid and rifampin resistance in clinical Mycobacterium tuberculosis isolates. Eur J Clin Microbiol Infect Dis 2008. Published online 22 Aug 2008, doi:10.1007/s10096-008-0584-5
   PubMedGoogle Scholar
• Jureen P, Engstrand L, Eriksson S, et al. Rapid detection of rifampin resistance in Mycobacterium tuberculosis by Pyrosequencing technology. J Clin Microbiol 2006;44:1925-9
   PubMed Web of Science ®Google Scholar
• Arnold C, Westland L, Mowat G, et al. Single-nucleotide polymorphism-based differentiation and drug resistance detection in Mycobacterium tuberculosis from isolates or directly from sputum. Clin Microbiol Infect 2005;11:122-30
   PubMed Web of Science ®Google Scholar
• Sheng J, Li J, Sheng G, et al. Characterization of rpoB mutations associated with rifampin resistance in Mycobacterium tuberculosis from eastern China. J Appl Microbiol 2008;105:904-11
   PubMed Web of Science ®Google Scholar
• Cheng X, Zhang J, Yang L, et al. A new Multi-PCR-SSCP assay for simultaneous detection of isoniazid and rifampin resistance in Mycobacterium tuberculosis. J Microbiol Methods 2007;70:301-5
   PubMed Web of Science ®Google Scholar
• Isfahani BN, Tavakoli A, Salehi M, Tazhibi M. Detection of rifampin resistance patterns in Mycobacterium tuberculosis strains isolated in Iran by polymerase chain reaction-single-strand conformation polymorphism and direct sequencing methods. Mem Inst Oswaldo Cruz 2006;101:597-602
   PubMed Web of Science ®Google Scholar
• Hofling CC, Pavan EM, Giampaglia CMS, et al. Prevalence of katG Ser315 substitution and rpoB mutations in isoniazid-resistant Mycobacterium tuberculosis isolates from Brazil. Int J Tuberc Lung Dis 2005;9:87-93
   PubMed Web of Science ®Google Scholar
• Mani C, Selvakumar N, Kumar V, et al. Comparison of DNA sequencing, PCR-SSCP and PhaB assays with indirect sensitivity testing for detection of rifampicin resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2003;7:652-9
   PubMed Web of Science ®Google Scholar
• Kim B, Lee K, Yun Y, et al. Simultaneous identification of rifampin-resistant Mycobacterium tuberculosis and nontuberculous mycobacteria by polymerase chain reaction-single strand conformation polymorphism and sequence analysis of the RNA polymerase gene (rpoB). J Microbiol Methods 2004;58:111-8
   PubMed Web of Science ®Google Scholar
• Wu X, Zhang J, Zhuang Y, et al. Molecular mechanisms of drug resistance in Mycobacterium tuberculosis clinical isolates. Chin Med J (Engl) 1999;112:524-8
   PubMed Web of Science ®Google Scholar
• Sharma M, Altamirano M, Prasad HK, et al. Characterization by single strand conformation polymorphism of mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis in strains from Vancouver, Mexico City and New Delhi. J Assoc Physicians India 2000;48:568-72
   PubMedGoogle Scholar
• Bobadilla-Del-Valle M, Ponce-De-Leon A, Arenas-Huertero C, et al. rpoB Gene mutations in rifampin-resistant Mycobacterium tuberculosis identified by polymerase chain reaction single-stranded conformational polymorphism. Emerg Infect Dis 2001;7:1010-3
   PubMed Web of Science ®Google Scholar
• Siddiqi N, Shamim M, Jain NK, et al. Molecular genetic analysis of multi-drug resistance in Indian isolates of Mycobacterium tuberculosis. Mem Inst Oswaldo Cruz 1998;93:589-94
   PubMed Web of Science ®Google Scholar
• Lee H, Cho SN, Bang HE, et al. Molecular analysis of rifampin-resistant Mycobacterium tuberculosis isolated from Korea by polymerase chain reaction-single strand conformation polymorphism sequence analysis. Int J Tuberc Lung Dis 1998;2:585-9
   PubMed Web of Science ®Google Scholar
• Cooksey R, Morlock G, Holloway B, et al. Comparison of Two Nonradioactive, Single-Strand Conformation Polymorphism Electrophoretic Methods for Identification of rpoB Mutations in Rifampin-Resistant Isolates of Mycobacterium tuberculosis. Mol Diagn 1998;3:73-9
   PubMedGoogle Scholar
• Cingolani A, Antinori A, Sanguinetti M, et al. Application of molecular methods for detection and transmission analysis of mycobacterium tuberculosis drug resistance in patients attending a reference hospital in Italy. J Infect Dis 1999;179:1025-9
   PubMed Web of Science ®Google Scholar
• Scarpellini P, Braglia S, Brambilla AM, et al. Detection of rifampin resistance by single-strand conformation polymorphism analysis of cerebrospinal fluid of patients with tuberculosis of the central nervous system. J Clin Microbiol 1997;35:2802-6
   PubMed Web of Science ®Google Scholar
• Kim BJ, Kim SY, Park BH, et al. Mutations in the rpoB gene of Mycobacterium tuberculosis that interfere with PCR-single-strand conformation polymorphism analysis for rifampin susceptibility testing. J Clin Microbiol 1997;35:492-4
   PubMed Web of Science ®Google Scholar
• Tracevska T, Jansone I, Broka L, et al. Mutations in the rpoB and katG genes leading to drug resistance in Mycobacterium tuberculosis in Latvia. J Clin Microbiol 2002;40:3789-92
   PubMed Web of Science ®Google Scholar
• Victor TC, Warren R, Butt JL, et al. Genome and MIC stability in Mycobacterium tuberculosis and indications for continuation of use of isoniazid in multidrug-resistant tuberculosis. J Med Microbiol 1997;46:847-57
   PubMed Web of Science ®Google Scholar
• Torres MJ, Criado A, Palomares JC, Aznar J. Use of real-time PCR and fluorimetry for rapid detection of rifampin and isoniazid resistance-associated mutations in Mycobacterium tuberculosis. J Clin Microbiol 2000;38:3194-9
   PubMed Web of Science ®Google Scholar
• Piana A, Orru M, Masia MD, et al. Detection of isoniazid and rifampin resistance in Mycobacterium tuberculosis strains by single-strand conformation polymorphism analysis and restriction fragment length polymorphism. New Microbiol 2003;26:375-81
   PubMedGoogle Scholar
• Gong G, Lee H, Kang GH, et al. Nested PCR for diagnosis of tuberculous lymphadenitis and PCR-SSCP for identification of rifampicin resistance in fine-needle aspirates. Diagn Cytopathol 2002;26:228-31
   PubMed Web of Science ®Google Scholar
• Felmlee TA, Liu Q, Whelen AC, et al. Genotypic detection of Mycobacterium tuberculosis rifampin resistance: comparison of single-strand conformation polymorphism and dideoxy fingerprinting. J Clin Microbiol 1995;33:1617-23
   PubMed Web of Science ®Google Scholar
• Torres MJ, Criado A, Gonzalez N, et al. Rifampin and isoniazid resistance associated mutations in Mycobacterium tuberculosis clinical isolates in Seville, Spain. Int J Tuberc Lung Dis 2002;6:160-3
   PubMed Web of Science ®Google Scholar
• Tesic J, Lepsanovic Z, Mirovic V. Evaluation of usefulness of single-strand conformation polymorphism method for rapid detection of rifampicin-resistant Mycobacterium tuberculosis. Vojnosanit Pregl 2004;61:169-72
   PubMedGoogle Scholar
• Sreevatsan S, Bookout J, Ringpis F, et al. Comparative Evaluation of Cleavase Fragment Length Polymorphism With PCR-SSCP and PCR-RFLP to Detect Antimicrobial Agent Resistance in Mycobacterium tuberculosis. Mol Diagn 1998;3:81-91
   PubMedGoogle Scholar
• Pretorius GS, Sirgel FA, Schaaf HS, et al. Rifampicin resistance in Mycobacterium tuberculosis–rapid detection and implications in chemotherapy. S Afr Med J 1996;86:50-5
   PubMed Web of Science ®Google Scholar
• Gonzalez N, Torres MJ, Aznar J, Palomares JC. Molecular analysis of rifampin and isoniazid resistance of Mycobacterium tuberculosis clinical isolates in Seville, Spain. Tuberc Lung Dis 1999;79:187-90
   PubMedGoogle Scholar
• Saribas Z, Kocagoz T, Alp A, Gunalp A. Rapid detection of rifampin resistance in Mycobacterium tuberculosis isolates by heteroduplex analysis and determination of rifamycin cross-resistance in rifampin-resistant isolates. J Clin Microbiol 2003;41:816-8
   PubMed Web of Science ®Google Scholar
• Nachamkin I, Kang C, Weinstein MP. Detection of resistance to isoniazid, rifampin, and streptomycin in clinical isolates of Mycobacterium tuberculosis by molecular methods. Clin Infect Dis 1997;24:894-900
   PubMed Web of Science ®Google Scholar
• Williams DL, Spring L, Gillis TP, et al. Evaluation of a polymerase chain reaction-based universal heteroduplex generator assay for direct detection of rifampin susceptibility of Mycobacterium tuberculosis from sputum specimens. Clin Infect Dis 1998;26:446-50
   PubMed Web of Science ®Google Scholar
• Thomas GA, Williams DL, Soper SA. Capillary electrophoresis-based heteroduplex analysis with a universal heteroduplex generator for detection of point mutations associated with rifampin resistance in tuberculosis. Clin Chem 2001;47:1195-203
   PubMed Web of Science ®Google Scholar
• Kiepiela P, Bishop K, Kormuth E, et al. Comparison of PCR-heteroduplex characterization by automated DNA sequencing and line probe assay for the detection of rifampicin resistance in Mycobacterium tuberculosis isolates from KwaZulu-Natal, South Africa. Microb Drug Resist 1998;4:263-9
   PubMed Web of Science ®Google Scholar
• Mayta H, Gilman RH, Arenas F, et al. Evaluation of a PCR-based universal heteroduplex generator assay as a tool for rapid detection of multidrug-resistant Mycobacterium tuberculosis in Peru. J Clin Microbiol 2003;41:5774-7
   PubMed Web of Science ®Google Scholar
• Nash KA, Gaytan A, Inderlied CB. Detection of rifampin resistance in Mycobacterium tuberculosis by use of a rapid, simple, and specific RNA/RNA mismatch assay. J Infect Dis 1997;176:533-6
   PubMed Web of Science ®Google Scholar
• Mokrousov I, Filliol I, Legrand E, et al. Molecular characterization of multiple-drug-resistant Mycobacterium tuberculosis isolates from northwestern Russia and analysis of rifampin resistance using RNA/RNA mismatch analysis as compared to the line probe assay and sequencing of the rpoB gene. Res Microbiol 2002;153:213-9
   PubMed Web of Science ®Google Scholar
• McCammon MT, Gillette JS, Thomas DP, et al. Detection of rpoB mutations associated with rifampin resistance in Mycobacterium tuberculosis using denaturing gradient gel electrophoresis. Antimicrob Agents Chemother 2005;49:2200-9
   PubMed Web of Science ®Google Scholar
• Liu YC, Huang TS, Huang WK, et al. Dideoxy fingerprinting for rapid screening of rpoB gene mutations in clinical isolates of Mycobacterium tuberculosis. J Formos Med Assoc 1998;97:400-4
   PubMed Web of Science ®Google Scholar
• Cooksey RC, Holloway BP, Oldenburg MC, et al. Evaluation of the invader assay, a linear signal amplification method, for identification of mutations associated with resistance to rifampin and isoniazid in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2000;44:1296-301
   PubMed Web of Science ®Google Scholar
• Brossier F, Veziris N, Truffot-Pernot C, et al. Performance of the genotype MTBDR line probe assay for detection of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosis with low- and high-level resistance. J Clin Microbiol 2006;44:3659-64
   PubMed Web of Science ®Google Scholar
• Al-Mutairi N, Ahmad S, Mokaddas E. Performance of the genotype MTBDR assay for molecular detection of multidrug-resistant strains of Mycobacterium tuberculosis. Ann Saudi Med 2008;28:203-6
   PubMed Web of Science ®Google Scholar
• Miotto P, Piana F, Penati V, et al. Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy. J Clin Microbiol 2006;44:2485-91
   PubMed Web of Science ®Google Scholar
• Makinen J, Marttila HJ, Marjamaki M, et al. Comparison of two commercially available DNA line probe assays for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2006;44:350-2
   PubMed Web of Science ®Google Scholar
• Hillemann D, Weizenegger M, Kubica T, et al. Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J Clin Microbiol 2005;43:3699-703
   PubMed Web of Science ®Google Scholar
• Cavusoglu C, Turhan A, Akinci P, Soyler I. Evaluation of the Genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis isolates. J Clin Microbiol 2006;44:2338-42
   PubMed Web of Science ®Google Scholar
• Akpaka PE, Baboolal S, Clarke D, et al. Evaluation of methods for rapid detection of resistance to isoniazid and rifampin in Mycobacterium tuberculosis isolates collected in the Caribbean. J Clin Microbiol 2008;46:3426-8
   PubMed Web of Science ®Google Scholar
• Rossau R, Traore H, De Beenhouwer H, et al. Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob Agents Chemother 1997;41:2093-8
   PubMed Web of Science ®Google Scholar
• Marttila HJ, Soini H, Vyshnevskiy BI, et al. Rapid detection of rifampin-resistant Mycobacterium tuberculosis by sequencing and line probe assay. Scand J Infect Dis 1998;30:129-32
   PubMed Web of Science ®Google Scholar
• Gamboa F, Cardona PJ, Manterola JM, et al. Evaluation of a commercial probe assay for detection of rifampin resistance in Mycobacterium tuberculosis directly from respiratory and nonrespiratory clinical samples. Eur J Clin Microbiol Infect Dis 1998;17:189-92
   PubMed Web of Science ®Google Scholar
• Sintchenko V, Chew WK, Jelfs PJ, Gilbert GL. Mutations in rpoB gene and rifabutin susceptibility of multidrug-resistant Mycobacterium tuberculosis strains isolated in Australia. Pathology 1999;31:257-60
   PubMed Web of Science ®Google Scholar
• Marttila HJ, Soini H, Vyshnevskaya E, et al. Line probe assay in the rapid detection of rifampin-resistant Mycobacterium tuberculosis directly from clinical specimens. Scand J Infect Dis 1999;31:269-73
   PubMed Web of Science ®Google Scholar
• Liu YC, Huang TS, Huang WK. Line probe assay for rapid detection of mutations in the rpoB gene of Mycobacterium tuberculosis. J Formos Med Assoc 1999;98:582-5
   PubMed Web of Science ®Google Scholar
• Hirano K, Abe C, Takahashi M. Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay. J Clin Microbiol 1999;37:2663-6
   PubMed Web of Science ®Google Scholar
• de Oliveira MM, da Silva Rocha A, Cardoso Oelemann M, et al. Rapid detection of resistance against rifampicin in isolates of Mycobacterium tuberculosis from Brazilian patients using a reverse-phase hybridization assay. J Microbiol Methods 2003;53:335-42
   PubMed Web of Science ®Google Scholar
• Bartfai Z, Somoskovi A, Kodmon C, et al. Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay. J Clin Microbiol 2001;39:3736-9
   PubMed Web of Science ®Google Scholar
• Ahmad S, Mokaddas E, Fares E. Characterization of rpoB mutations in rifampin-resistant clinical Mycobacterium tuberculosis isolates from Kuwait and Dubai. Diagn Microbiol Infect Dis 2002;44:245-52
   PubMed Web of Science ®Google Scholar
• Ahmad S, Araj GF, Akbar PK, et al. Characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from the Middle East. Diagn Microbiol Infect Dis 2000;38:227-32
   PubMed Web of Science ®Google Scholar
• Somoskovi A, Song Q, Mester J, et al. Use of molecular methods to identify the Mycobacterium tuberculosis complex (MTBC) and other mycobacterial species and to detect rifampin resistance in MTBC isolates following growth detection with the BACTEC MGIT 960 system. J Clin Microbiol 2003;41:2822-6
   PubMed Web of Science ®Google Scholar
• Sharma M, Sethi S, Mishra B, et al. Rapid detection of mutations in rpoB gene of rifampicin resistant Mycobacterium tuberculosis strains by line probe assay. Indian J Med Res 2003;117:76-80
   PubMed Web of Science ®Google Scholar
• Lemus D, Martin A, Montoro E, et al. Rapid alternative methods for detection of rifampicin resistance in Mycobacterium tuberculosis. J Antimicrob Chemother 2004;54:130-3
   PubMed Web of Science ®Google Scholar
• Herrera L, Jimenez S, Valverde A, et al. Molecular analysis of rifampicin-resistant Mycobacterium tuberculosis isolated in Spain (1996-2001). Description of new mutations in the rpoB gene and review of the literature. Int J Antimicrob Agents 2003;21:403-8
   PubMed Web of Science ®Google Scholar
• Srivastava K, Das R, Jakhmola P, et al. Correlation of mutations detected by INNO-LiPA with levels of rifampicin resistance in Mycobacterium tuberculosis. Indian J Med Res 2004;120:100-5
   PubMed Web of Science ®Google Scholar
• Skenders G, Fry AM, Prokopovica I, et al. Multidrug-resistant tuberculosis detection, Latvia. Emerg Infect Dis 2005;11:1461-3
   PubMed Web of Science ®Google Scholar
• Jureen P, Werngren J, Hoffner SE. Evaluation of the line probe assay (LiPA) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. Tuberculosis (Edinb) 2004;84:311-6
   PubMed Web of Science ®Google Scholar
• Ahmad S, Mokaddas E. The occurrence of rare rpoB mutations in rifampicin-resistant clinical Mycobacterium tuberculosis isolates from Kuwait. Int J Antimicrob Agents 2005;26:205-12
   PubMed Web of Science ®Google Scholar
• Tortoli E, Marcelli F. Use of the INNO LiPA Rif.TB for detection of Mycobacterium tuberculosis DNA directly in clinical specimens and for simultaneous determination of rifampin susceptibility. Eur J Clin Microbiol Infect Dis 2007;26:51-5
   PubMed Web of Science ®Google Scholar
• Sam I, Drobniewski F, More P, et al. Mycobacterium tuberculosis and rifampin resistance, United Kingdom. Emerg Infect Dis 2006;12:752-9
   PubMed Web of Science ®Google Scholar
• Ozkutuk N, Gazi H, Surucuoglu S, et al. Characterization of rpoB mutations by line probe assay in rifampicin-resistant mycobacterium tuberculosis clinical isolates from the aegean region in Turkey. Jpn J Infect Dis 2007;60:211-3
   PubMed Web of Science ®Google Scholar
• Toungoussova OS, Sandven P, Mariandyshev AO, et al. Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast, Russia. J Clin Microbiol 2002;40:1930-7
   PubMed Web of Science ®Google Scholar
• Soudani A, Hadjfredj S, Zribi M, et al. Characterization of Tunisian Mycobacterium tuberculosis rifampin-resistant clinical isolates. J Clin Microbiol 2007;45:3095-7
   PubMed Web of Science ®Google Scholar
• Negi SS, Anand R, Pasha ST, et al. Molecular characterization of mutation associated with rifampicin and isoniazid resistance in Mycobacterium tuberculosis isolates. Indian J Exp Biol 2006;44:547-53
   PubMedGoogle Scholar
• March F, Garriga X, Rodriguez P, et al. Acquired drug resistance in Mycobacterium tuberculosis isolates recovered from compliant patients with human immunodeficiency virus-associated tuberculosis. Clin Infect Dis 1997;25:1044-7
   PubMed Web of Science ®Google Scholar
• Cooksey RC, Morlock GP, Glickman S, Crawford JT. Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from New York City. J Clin Microbiol 1997;35:1281-3
   PubMed Web of Science ®Google Scholar
• Cirillo DM, Piana F, Frisicale L, et al. Direct rapid diagnosis of rifampicin-resistant M. tuberculosis infection in clinical samples by line probe assay (INNO LiPA Rif-TB). New Microbiol 2004;27:221-7
   PubMedGoogle Scholar
• Matsiota-Bernard P, Vrioni G, Marinis E. Characterization of rpoB mutations in rifampin-resistant clinical Mycobacterium tuberculosis isolates from Greece. J Clin Microbiol 1998;36:20-3
   PubMed Web of Science ®Google Scholar
• McNerney R, Kiepiela P, Bishop KS, et al. Rapid screening of Mycobacterium tuberculosis for susceptibility to rifampicin and streptomycin. Int J Tuberc Lung Dis 2000;4:69-75
   PubMed Web of Science ®Google Scholar
• Goyal M, Shaw RJ, Banerjee DK, et al. Rapid detection of multidrug-resistant tuberculosis. Eur Respir J 1997;10:1120-4
   PubMed Web of Science ®Google Scholar
• Viader-Salvado JM, Luna-Aguirre CM, Reyes-Ruiz JM, et al. Frequency of mutations in rpoB and codons 315 and 463 of katG in rifampin- and/or isoniazid-resistant Mycobacterium tuberculosis isolates from northeast Mexico. Microb Drug Resist 2003;9:33-8
   PubMed Web of Science ®Google Scholar
• Traore H, van Deun A, Shamputa IC, et al. Direct detection of Mycobacterium tuberculosis complex DNA and rifampin resistance in clinical specimens from tuberculosis patients by line probe assay. J Clin Microbiol 2006;44:4384-8
   PubMed Web of Science ®Google Scholar
• Quezada CM, Kamanzi E, Mukamutara J, et al. Implementation validation performed in Rwanda to determine whether the INNO-LiPA Rif.TB line probe assay can be used for detection of multidrug-resistant Mycobacterium tuberculosis in low-resource countries. J Clin Microbiol 2007;45:3111-4
   PubMed Web of Science ®Google Scholar
• Alvarado-Esquivel C, Rossau R, Martinez-Garcia S, et al. Characterization of rpoB gene mutations in rifampicin resistant Mycobacterium tuberculosis strains isolated from pulmonary tuberculosis patients at 5 Mexican public hospitals. Rev Invest Clin 2001;53:526-30
   PubMed Web of Science ®Google Scholar
• Sougakoff W, Rodrigue M, Truffot-Pernot C, et al. Use of a high-density DNA probe array for detecting mutations involved in rifampicin resistance in Mycobacterium tuberculosis. Clin Microbiol Infect 2004;10:289-94
   PubMed Web of Science ®Google Scholar
• Shimizu Y, Dobashi K, Yoshikawa Y, et al. Five-antituberculosis Drug-resistance Genes Detection Using Array System. J Clin Biochem Nutr 2008;42:228-34
   PubMed Web of Science ®Google Scholar
• Park H, Song EJ, Song ES, et al. Comparison of a conventional antimicrobial susceptibility assay to an oligonucleotide chip system for detection of drug resistance in Mycobacterium tuberculosis isolates. J Clin Microbiol 2006;44:1619-24
   PubMed Web of Science ®Google Scholar
• Deng J, Zhang X, Lu H, et al. Multiplex detection of mutations in clinical isolates of rifampin-resistant Mycobacterium tuberculosis by short oligonucleotide ligation assay on DNA chips. J Clin Microbiol 2004;42:4850-2
   PubMed Web of Science ®Google Scholar
• Aragon LM, Navarro F, Heiser V, et al. Rapid detection of specific gene mutations associated with isoniazid or rifampicin resistance in Mycobacterium tuberculosis clinical isolates using non-fluorescent low-density DNA microarrays. J Antimicrob Chemother 2006;57:825-31
   PubMed Web of Science ®Google Scholar
• Zhang S, Shen J, Xu P, et al. A novel genotypic test for rapid detection of multidrug-resistant Mycobacterium tuberculosis isolates by a multiplex probe array. J Appl Microbiol 2007;103:1262-71
   PubMed Web of Science ®Google Scholar
• Mikhailovich V, Lapa S, Gryadunov D, et al. Identification of rifampin-resistant Mycobacterium tuberculosis strains by hybridization, PCR, and ligase detection reaction on oligonucleotide microchips. J Clin Microbiol 2001;39:2531-40
   PubMed Web of Science ®Google Scholar
• Kim S, Park Y, Song E, et al. Evaluation of the CombiChip Mycobacteria Drug-Resistance detection DNA chip for identifying mutations associated with resistance to isoniazid and rifampin in Mycobacterium tuberculosis. Diagn Microbiol Infect Dis 2006;54:203-10
   PubMed Web of Science ®Google Scholar
• Gryadunov D, Mikhailovich V, Lapa S, et al. Evaluation of hybridisation on oligonucleotide microarrays for analysis of drug-resistant Mycobacterium tuberculosis. Clin Microbiol Infect 2005;11:531-9
   PubMed Web of Science ®Google Scholar
• Caoili JC, Mayorova A, Sikes D, et al. Evaluation of the TB-Biochip oligonucleotide microarray system for rapid detection of rifampin resistance in Mycobacterium tuberculosis. J Clin Microbiol 2006;44:2378-81
   PubMed Web of Science ®Google Scholar
• Yue J, Shi W, Xie J, et al. Detection of rifampin-resistant Mycobacterium tuberculosis strains by using a specialized oligonucleotide microarray. Diagn Microbiol Infect Dis 2004;48:47-54
   PubMed Web of Science ®Google Scholar
• Xu C, Zhou Y, Deng J, et al. On-chip ligation of multiplexing probe-pairs for identifying point mutations out of dense SNP loci. Biosens Bioelectron 2008. Published online 15 Jul 2008, doi:10.1016/j.bios.2008.07.009
   Google Scholar
• Gingeras TR, Ghandour G, Wang E, et al. Simultaneous genotyping and species identification using hybridization pattern recognition analysis of generic Mycobacterium DNA arrays. Genome Res 1998;8:435-48
   PubMed Web of Science ®Google Scholar
• Head SR, Parikh K, Rogers YH, et al. Solid-phase sequence scanning for drug resistance detection in tuberculosis. Mol Cell Probes 1999;13:81-7
   PubMed Web of Science ®Google Scholar
• Bockstahler LE, Li Z, Nguyen NY, et al. Peptide nucleic acid probe detection of mutations in Mycobacterium tuberculosis genes associated with drug resistance. Biotechniques 2002;32:508-10, 512, 514
   PubMed Web of Science ®Google Scholar
• Edwards KJ, Metherell LA, Yates M, Saunders NA. Detection of rpoB mutations in Mycobacterium tuberculosis by biprobe analysis. J Clin Microbiol 2001;39:3350-2
   PubMed Web of Science ®Google Scholar
• Wada T, Maeda S, Tamaru A, et al. Dual-probe assay for rapid detection of drug-resistant Mycobacterium tuberculosis by real-time PCR. J Clin Microbiol 2004;42:5277-85
   PubMed Web of Science ®Google Scholar
• Espasa M, Gonzalez-Martin J, Alcaide F, et al. Direct detection in clinical samples of multiple gene mutations causing resistance of Mycobacterium tuberculosis to isoniazid and rifampicin using fluorogenic probes. J Antimicrob Chemother 2005;55:860-5
   PubMed Web of Science ®Google Scholar
• Varma-Basil M, El-Hajj H, Colangeli R, et al. Rapid detection of rifampin resistance in Mycobacterium tuberculosis isolates from India and Mexico by a molecular beacon assay. J Clin Microbiol 2004;42:5512-6
   PubMed Web of Science ®Google Scholar
• Piatek AS, Tyagi S, Pol AC, et al. Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis. Nat Biotechnol 1998;16:359-63
   PubMed Web of Science ®Google Scholar
• Piatek AS, Telenti A, Murray MR, et al. Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrob Agents Chemother 2000;44:103-10
   PubMed Web of Science ®Google Scholar
• El-Hajj HH, Marras SA, Tyagi S, et al. Detection of rifampin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons. J Clin Microbiol 2001;39:4131-7
   PubMed Web of Science ®Google Scholar
• Marin M, Garcia de Viedma D, Ruiz-Serrano MJ, Bouza E. Rapid direct detection of multiple rifampin and isoniazid resistance mutations in Mycobacterium tuberculosis in respiratory samples by real-time PCR. Antimicrob Agents Chemother 2004;48:4293-300
   PubMed Web of Science ®Google Scholar
• Kocagoz T, Saribas Z, Alp A. Rapid determination of rifampin resistance in clinical isolates of Mycobacterium tuberculosis by real-time PCR. J Clin Microbiol 2005;43:6015-9
   PubMed Web of Science ®Google Scholar
• Sajduda A, Brzostek A, Poplawska M, et al. Molecular characterization of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland. J Clin Microbiol 2004;42:2425-31
   PubMed Web of Science ®Google Scholar
• Torres MJ, Criado A, Ruiz M, et al. Improved real-time PCR for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates. Diagn Microbiol Infect Dis 2003;45:207-12
   PubMed Web of Science ®Google Scholar
• Garcia de Viedma D, del Sol Diaz Infantes M, Lasala F, et al. New real-time PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosis. J Clin Microbiol 2002;40:988-95
   PubMed Web of Science ®Google Scholar
• Krishnamurthy A, Rodrigues C, Mehta AP. Rapid detection of rifampicin resistance in m.tuberculosis by phage assay. Indian J Med Microbiol 2002;20:211-4
   PubMedGoogle Scholar
• El-Sayed Zaki M, Goda T. Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB. Tuberculosis (Edinb) 2007;87:102-8
   PubMed Web of Science ®Google Scholar
• Albert H, Trollip AP, Linley K, et al. Development of an antimicrobial formulation for control of specimen-related contamination in phage-based diagnostic testing for tuberculosis. J Appl Microbiol 2007;103:892-9
   PubMed Web of Science ®Google Scholar
• Albert H, Heydenrych A, Mole R, et al. Evaluation of FASTPlaqueTB-RIF, a rapid, manual test for the determination of rifampicin resistance from Mycobacterium tuberculosis cultures. Int J Tuberc Lung Dis 2001;5:906-11
   PubMed Web of Science ®Google Scholar
• Kisa O, Albay A, Bedir O, et al. Evaluation of FASTPlaqueTB-RIF for determination of rifampicin resistance in Mycobacterium tuberculosis complex isolates. Int J Tuberc Lung Dis 2003;7:284-8
   PubMed Web of Science ®Google Scholar
• Butt T, Ahmad RN, Afzal RK, et al. Rapid detection of rifampicin susceptibility of Mycobacterium tuberculosis in sputum specimens by mycobacteriophage assay. J Pak Med Assoc 2004;54:379-82
   PubMedGoogle Scholar
• Albert H, Trollip AP, Mole RJ, et al. Rapid indication of multidrug-resistant tuberculosis from liquid cultures using FASTPlaqueTB-RIF, a manual phage-based test. Int J Tuberc Lung Dis 2002;6:523-8
   PubMed Web of Science ®Google Scholar
• da Silva PA, Boffo MMS, de Mattos IG, et al. Comparison of redox and D29 phage methods for detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis. Clin Microbiol Infect 2006;12:293-6
   PubMed Web of Science ®Google Scholar
• Yzquierdo SL, Lemus D, Echemendia M, et al. Evaluation of phage assay for rapid phenotypic detection of rifampicin resistance in Mycobacterium tuberculosis. Ann Clin Microbiol Antimicrob 2006;5:11
   PubMedGoogle Scholar
• Simboli N, Takiff H, McNerney R, et al. In-house phage amplification assay is a sound alternative for detecting rifampin-resistant Mycobacterium tuberculosis in low-resource settings. Antimicrob Agents Chemother 2005;49:425-7
   PubMed Web of Science ®Google Scholar
• Gali N, Dominguez J, Blanco S, et al. Utility of an in-house mycobacteriophage-based assay for rapid detection of rifampin resistance in Mycobacterium tuberculosis clinical isolates. J Clin Microbiol 2003;41:2647-9
   PubMed Web of Science ®Google Scholar
• Chauca JA, Palomino J, Guerra H. Evaluation of rifampicin and isoniazid susceptibility testing of Mycobacterium tuberculosis by a mycobacteriophage D29-based assay. J Med Microbiol 2007;56:360-4
   PubMed Web of Science ®Google Scholar
• Traore H, Ogwang S, Mallard K, et al. Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, Uganda. Ann Clin Microbiol Antimicrob 2007;6:1
   PubMedGoogle Scholar
• Eltringham IJ, Drobniewski FA, Mangan JA, et al. Evaluation of reverse transcription-PCR and a bacteriophage-based assay for rapid phenotypic detection of rifampin resistance in clinical isolates of Mycobacterium tuberculosis. J Clin Microbiol 1999;37:3524-7
   PubMed Web of Science ®Google Scholar
• Riska PF, Su Y, Bardarov S, et al. Rapid film-based determination of antibiotic susceptibilities of Mycobacterium tuberculosis strains by using a luciferase reporter phage and the Bronx Box. J Clin Microbiol 1999;37:1144-9
   PubMed Web of Science ®Google Scholar
• Hazbon MH, Guarin N, Ferro BE, et al. Photographic and luminometric detection of luciferase reporter phages for drug susceptibility testing of clinical Mycobacterium tuberculosis isolates. J Clin Microbiol 2003;41:4865-9
   PubMed Web of Science ®Google Scholar
• Banaiee N, January V, Barthus C, et al. Evaluation of a semi-automated reporter phage assay for susceptibility testing of Mycobacterium tuberculosis isolates in South Africa. Tuberculosis (Edinb) 2008;88:64-8
   PubMed Web of Science ®Google Scholar
• Banaiee N, Bobadilla-Del-Valle M, Riska PF, et al. Rapid identification and susceptibility testing of Mycobacterium tuberculosis from MGIT cultures with luciferase reporter mycobacteriophages. J Med Microbiol 2003;52:557-61
   PubMed Web of Science ®Google Scholar
• Banaiee N, Bobadilla-Del-Valle M, Bardarov SJ, et al. Luciferase reporter mycobacteriophages for detection, identification, and antibiotic susceptibility testing of Mycobacterium tuberculosis in Mexico. J Clin Microbiol 2001;39:3883-8
   PubMed Web of Science ®Google Scholar
• Jacobs WRJ, Barletta RG, Udani R, et al. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science 1993;260:819-22
   PubMed Web of Science ®Google Scholar
• McNerney R, Mallard K, Urassa HMR, et al. Colorimetric phage-based assay for detection of rifampin-resistant Mycobacterium tuberculosis. J Clin Microbiol 2007;45:1330-2
   PubMed Web of Science ®Google Scholar
• Reis RS, Neves IJ, Lourenco SLS, et al. Comparison of flow cytometric and Alamar Blue tests with the proportional method for testing susceptibility of Mycobacterium tuberculosis to rifampin and isoniazid. J Clin Microbiol 2004;42:2247-8
   PubMed Web of Science ®Google Scholar
• Palomino JC, Portaels F. Simple procedure for drug susceptibility testing of Mycobacterium tuberculosis using a commercial colorimetic assay. Eur J Clin Microbiol Infect Dis 1999;18:380-3
   PubMed Web of Science ®Google Scholar
• Luna-Herrera J, Martinez-Cabrera G, Parra-Maldonado R, et al. Use of receiver operating characteristic curves to assess the performance of a microdilution assay for determination of drug susceptibility of clinical isolates of Mycobacterium tuberculosis. Eur J Clin Microbiol Infect Dis 2003;22:21-7
   PubMed Web of Science ®Google Scholar
• Franzblau SG, Witzig RS, Mclaughlin JC, et al. Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J Clin Microbiol 1998;36:362-6
   PubMed Web of Science ®Google Scholar
• Chauca J, Palomino J, Guerra H. Evaluation of the accuracy of the microplate Alamar Blue assay for rapid detection of MDR-TB in Peru. Int J Tuberc Lung Dis 2007;11:820-2
   PubMed Web of Science ®Google Scholar
• Moore DAJ, Mendoza D, Gilman RH, et al. Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J Clin Microbiol 2004;42:4432-7
   PubMed Web of Science ®Google Scholar
• Mengatto L, Chiani Y, Imaz MS. Evaluation of rapid alternative methods for drug susceptibility testing in clinical isolates of Mycobacterium tuberculosis. Mem Inst Oswaldo Cruz 2006;101:535-42
   PubMed Web of Science ®Google Scholar
• Martin A, Morcillo N, Lemus D, et al. Multicenter study of MTT and resazurin assays for testing susceptibility to first-line anti-tuberculosis drugs. Int J Tuberc Lung Dis 2005;9:901-6
   PubMed Web of Science ®Google Scholar
• Foongladda S, Roengsanthia D, Arjrattanakool W, et al. Rapid and simple MTT method for rifampicin and isoniazid susceptibility testing of Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2002;6:1118-22
   PubMed Web of Science ®Google Scholar
• Abate G, Mshana RN, Miorner H. Evaluation of a colorimetric assay based on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 1998;2:1011-6
   PubMed Web of Science ®Google Scholar
• Caviedes L, Delgado J, Gilman RH. Tetrazolium microplate assay as a rapid and inexpensive colorimetric method for determination of antibiotic susceptibility of Mycobacterium tuberculosis. J Clin Microbiol 2002;40:1873-4
   PubMed Web of Science ®Google Scholar
• Mshana RN, Tadesse G, Abate G, Miorner H. Use of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide for rapid detection of rifampin-resistant Mycobacterium tuberculosis. J Clin Microbiol 1998;36:1214-9
   PubMed Web of Science ®Google Scholar
• De Logu A, Uda P, Pellerano ML, et al. Comparison of two rapid colorimetric methods for determining resistance of mycobacterium tuberculosis to rifampin, isoniazid, and streptomycin in liquid medium. Eur J Clin Microbiol Infect Dis 2001;20:33-9
   PubMed Web of Science ®Google Scholar
• Rivoire N, Ravololonandriana P, Rasolonavalona T, et al. Evaluation of the resazurin assay for the detection of multidrug-resistant Mycobacterium tuberculosis in Madagascar. Int J Tuberc Lung Dis 2007;11:683-8
   PubMed Web of Science ®Google Scholar
• Palomino J, Martin A, Camacho M, et al. Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2002;46:2720-2
   PubMed Web of Science ®Google Scholar
• Nateche F, Martin A, Baraka S, et al. Application of the resazurin microtitre assay for detection of multidrug resistance in Mycobacterium tuberculosis in Algiers. J Med Microbiol 2006;55:857-60
   PubMed Web of Science ®Google Scholar
• Banfi E, Scialino G, Monti-Bragadin C. Development of a microdilution method to evaluate Mycobacterium tuberculosis drug susceptibility. J Antimicrob Chemother 2003;52:796-800
   PubMed Web of Science ®Google Scholar
• Affolabi D, Sanoussi N, Odoun M, et al. Rapid detection of multidrug-resistant Mycobacterium tuberculosis in Cotonou (Benin) using two low-cost colorimetric methods: resazurin and nitrate reductase assays. J Med Microbiol 2008;57:1024-7
   PubMed Web of Science ®Google Scholar
• Honscha G, Von Groll A, Valenca M, et al. The laboratory as a tool to qualify tuberculosis diagnosis. Int J Tuberc Lung Dis 2008;12:218-20
   PubMed Web of Science ®Google Scholar
• De Logu A, Pellerano ML, Sanna A, et al. Comparison of the susceptibility testing of clinical isolates of Mycobacterium tuberculosis by the XTT colorimetric method and the NCCLS standards method. Int J Antimicrob Agents 2003;21:244-50
   PubMed Web of Science ®Google Scholar
• De Logu A, Borgna R, Uda P, et al. The 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) assay as rapid colorimetric method for determination of antibiotic susceptibility of clinical Mycobacterium tuberculosis isolates in liquid medium. Clin Lab 2003;49:357-65
   PubMedGoogle Scholar
• Lee S, Kong DH, Yun SH, et al. Evaluation of a modified antimycobacterial susceptibility test using Middlebrook 7H10 agar containing 2,3-diphenyl-5-thienyl-(2)-tetrazolium chloride. J Microbiol Methods 2006;66:548-51
   PubMed Web of Science ®Google Scholar
• Mohammadzadeh A, Farnia P, Ghazvini K, et al. Rapid and low-cost colorimetric method using 2,3,5-triphenyltetrazolium chloride for detection of multidrug-resistant Mycobacterium tuberculosis. J Med Microbiol 2006;55:1657-9
   PubMed Web of Science ®Google Scholar
• Asencios L, Yale G, Yagui M, et al. Programmatic implementation of rapid DST for Mycobacterium tuberculosisin Peru. Int J Tuberc Lung Dis 2008;12:743-9
   PubMed Web of Science ®Google Scholar
• Sethi S, Sharma S, Sharma SK, et al. Drug susceptibility of Mycobacterium tuberculosis to primary antitubercular drugs by nitrate reductase assay. Indian J Med Res 2004;120:468-71
   PubMed Web of Science ®Google Scholar
• Martin A, Montoro E, Lemus D, et al. Multicenter evaluation of the nitrate reductase assay for drug resistance detection of Mycobacterium tuberculosis. J Microbiol Methods 2005;63:145-50
   PubMed Web of Science ®Google Scholar
• Lemus D, Montoro E, Echemendia M, et al. Nitrate reductase assay for detection of drug resistance in Mycobacterium tuberculosis: simple and inexpensive method for low-resource laboratories. J Med Microbiol 2006;55:861-3
   PubMed Web of Science ®Google Scholar
• Coban AY, Birinci A, Ekinci B, et al. Drug susceptibility testing of Mycobacterium tuberculosis with nitrate reductase assay. Int J Antimicrob Agents 2004;24:304-6
   PubMed Web of Science ®Google Scholar
• Angeby KAK, Klintz L, Hoffner SE. Rapid and inexpensive drug susceptibility testing of Mycobacterium tuberculosis with a nitrate reductase assay. J Clin Microbiol 2002;40:553-5
   PubMed Web of Science ®Google Scholar
• Syre H, Phyu S, Sandven P, et al. Rapid colorimetric method for testing susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin in liquid cultures. J Clin Microbiol 2003;41:5173-7
   PubMed Web of Science ®Google Scholar
• Shiferaw G, Woldeamanuel Y, Gebeyehu M, et al. Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2007;45:1093-7
   PubMed Web of Science ®Google Scholar
• Mello FCQ, Arias MS, Rosales S, et al. Clinical evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to isoniazid or rifampin. J Clin Microbiol 2007;45:3387-9
   PubMed Web of Science ®Google Scholar
• Ejigu GS, Woldeamanuel Y, Shah NS, et al. Microscopic-observation drug susceptibility assay provides rapid and reliable identification of MDR-TB. Int J Tuberc Lung Dis 2008;12:332-7
   PubMed Web of Science ®Google Scholar